Schonfeld Strategic Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $40.7K | Sell |
|
|||||
|
2024
Q3 | $323K | Sell |
|
|||||
|
2024
Q2 | $498K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.34M | Buy |
|
|||||
|
2023
Q3 | $2.31M | Buy |
|
|||||
|
2023
Q2 | $2.13M | Buy |
|
|||||
|
2023
Q1 | $1.77M | Sell |
|
|||||
|
2022
Q4 | $3.16M | Sell |
|
|||||
|
2022
Q3 | $5.86M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $293K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $2.58M | Sell |
|
|||||
|
2017
Q4 | $3.41M | Buy |
|